Beyond Measurement: Insights from May Measurement Month 2023 in Bahrain
Clicks: 3
ID: 319069
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.6
/100
3 views
2 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #128 of 282 articles by views in European heart journal supplements : journal of the European Society of Cardiology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 282 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract The May Measurement Month (MMM) campaign operated in Bahrain during 2023 to increase public awareness about elevated blood pressure (BP). The study enrolled participants aged 18 and above through opportunistic sampling at healthcare facilities and shopping malls and workplace locations. Three seated BP readings were obtained from each participant while a questionnaire gathered data about their demographic characteristics and their lifestyle habits and medical conditions. The study defined hypertension as systolic BP ≥140mmHg or diastolic BP ≥90mmHg (based on the mean of the second and third readings), or current use of BP-lowering medication. The study defined controlled BP as <140/90mmHg in patients who received BP-lowering medication. The study included 2,829 participants with an average age of 46.9 years and consisted of 41.9% female participants. The study revealed that 1,145 participants (40.5%) had hypertension, of whom 730 (63.8%) participants were aware of their condition and 710 (62.0%) participants received BP-lowering treatment. The study showed that 57.7% of participants taking BP-lowering medication achieved controlled BP levels, representing 35.8% of all hypertensive participants. Participants with hypertension had higher body mass index values than participants without hypertension (30.4 vs 27.5 kg/m2, p<0.001). The MMM23 programme proved that opportunistic BP screening can be successfully conducted in Bahrain. The ongoing participation in MMM will enable continuous disease monitoring, which will help develop national plans to decrease cardiovascular disease rates.
| Reference Key |
openalex_W7166533290
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Dalal Alromaihi, Mariam Al-Hajeri, Ameera Al Nooh, Hamad Saif, Thomas Beaney, Gabriele Kerr |
| Journal | European heart journal supplements : journal of the European Society of Cardiology |
| Year | 2026 |
| DOI |
10.1093/eurheartjsupp/suag085
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.